XML 254 R229.htm IDEA: XBRL DOCUMENT v3.23.1
RISK MANAGEMENT - Individual evaluation of impairment for other financial instruments (Details) - COP ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Debt instruments      
RISK MANAGEMENT      
Maximum exposure $ 27,431,181 $ 28,833,828  
Debt instruments | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 27,431,181 28,833,828  
Impairment (67,189) (27,923)  
Final Exposure 27,363,992 28,805,905  
Equity      
RISK MANAGEMENT      
Maximum exposure 573,855 480,153  
Impairment 0 0 $ 0
Equity | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 573,855 480,153  
Impairment 0 0  
Final Exposure 573,855 480,153  
Fair value | Debt instruments | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 19,029,919 15,036,467  
Impairment (2,286)    
Final Exposure 19,027,633 15,036,467  
Amortized Cost | Debt instruments | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 8,401,262 13,797,361  
Impairment (64,903) (27,923)  
Final Exposure 8,336,359 13,769,438  
Fair Value through profit or loss | Equity | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 90,538 85,244  
Impairment 0 0  
Final Exposure 90,538 85,244  
Fair Value through OCI | Equity | Individual evaluation      
RISK MANAGEMENT      
Maximum exposure 483,317 394,909  
Impairment 0 0  
Final Exposure $ 483,317 $ 394,909